Exploratory Clinical Trial of Honghua Xiaoyao Pills for the Treatment of Liver Depression and Haemostasis‐Type Hyperplasia of Mammary Glands: A Single‐Centre, Single‐Arm Study
Open Access
- 1 January 2026
- journal article
- clinical trial
- Published by Wiley in The Breast Journal
- Vol. 2026 (1) , e3499662
Abstract
Background: Hyperplasia of mammary glands (HMG) is a common benign disease of the female breast. Objective: This study aimed to observe the clinical efficacy and safety of Honghua Xiaoyao pills in the treatment of liver depression and haemostasis‐type HMG, as well as their impact on menstruation. Methods: Sixty patients diagnosed with liver depression and haemostasis‐type HMG in the breast disease department of our hospital were selected as the study participants. The treatment involved oral administration of Honghua Xiaoyao pills: four pills per dose, three times a day, for a duration of 3 months without interruption during menstruation. Hormones, Western painkillers and similar Chinese herbal medicines were prohibited during the trial. Changes in breast pain, breast masses, menstrual volume and safety indicators were observed. Results: Three patients were lost to follow‐up after 2 months of treatment, and four patients voluntarily withdrew from the study. The changes in breast pain scores, breast mass size scores and breast mass texture scores relative to baseline and their respective change rates showed statistically significant differences ( p < 0.0001). Changes in lower abdominal distension, breast distension, menstrual blood clots, chest tightness/discomfort and emotional scores relative to baseline were also statistically significant ( p < 0.0001). Conclusion: Honghua Xiaoyao pills are effective in reducing breast pain, shrinking breast masses and improving lower abdominal distension, breast distension, menstrual blood clots, chest tightness/discomfort and emotional symptoms in patients with liver depression and haemostasis‐type HMG. Trial Registration: International Traditional Medicine Clinical Trial Registry: ITMCTR2024000165Keywords
This publication has 20 references indexed in Scilit:
- Network pharmacology and molecular docking technology for exploring the effect and mechanism of Radix Bupleuri and Radix Paeoniae Alba herb-pair on anti-hepatitis: A reviewMedicine, 2023
- Mechanisms of single herbs and herbal pairs in the treatment of mammary gland hyperplasia: An integrated reviewHeliyon, 2023
- [Mechanism of blood-activating and mass-dissipating Chinese patent medicine against hyperplasia of mammary glands and use with other medicine: a review].2023
- A review on the advances in the extraction methods and structure elucidation of Poria cocos polysaccharide and its pharmacological activities and drug carrier applicationsInternational Journal of Biological Macromolecules, 2022
- Dose‐Dependent Effects of Royal Jelly on Estrogen‐ and Progesterone‐Induced Mammary Gland Hyperplasia in RatsMolecular Nutrition & Food Research, 2021
- Molecular basis for Poria cocos mushroom polysaccharide used as an antitumour drug in ChinaJournal of Cellular and Molecular Medicine, 2018
- Advancement in the chemical analysis of Paeoniae Radix (Shaoyao)Journal of Pharmaceutical and Biomedical Analysis, 2018
- A systematic review of the active saikosaponins and extracts isolated from Radix Bupleuri and their applicationsPharmaceutical Biology, 2016
- Phytochemistry and Pharmacology ofCarthamus tinctoriusL.The American Journal of Chinese Medicine, 2016
- Phytochemistry, pharmacology and medicinal properties of Carthamus tinctorius L.Chinese Journal of Integrative Medicine, 2013